Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis

Rodi, Maria ORCID: 0000-0001-6578-0851, de Lastic, Anne-Lise ORCID: 0000-0002-3152-4777, Panagoulias, Ioannis, Aggeletopoulou, Ioanna ORCID: 0000-0003-4489-1485, Kelaidonis, Kostas, Matsoukas, John ORCID: 0000-0001-5554-2964, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Mouzaki, Athanasia ORCID: 0000-0001-5548-7002 (2024) Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International Journal of Molecular Sciences, 25 (11). ISSN 1661-6596 (print) 1422-0067 (online)

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/48919
DOI 10.3390/ijms25116092
Official URL https://www.mdpi.com/1422-0067/25/11/6092
Subjects Current > FOR (2020) Classification > 3202 Clinical sciences
Current > FOR (2020) Classification > 3204 Immunology
Current > Division/Research > Institute for Health and Sport
Keywords peptides; MOG35–55; mannan; vitamin D; dendritic cells; cytokines; regulatory T cells; immunomodulation; human
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login